Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life

Background: Janus kinase inhibitors (JAKis) represent a new alternative to treat rheumatoid arthritis (RA). The objective of this study was to evaluate the effectiveness, tolerance profile, and maintenance of these treatments (tofacitinib and baricitinib) in real life. Methods: All patients in the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Deprez, Valentine, Le Monnier, Laure, Sobhy-Danial, Jean-Marc, Grados, Franck, Henry-Desailly, Isabelle, Salomon-Goëb, Sarah, Rabin, Thibault, Ristic, Sanja, Fumery, Mathurin, Fardellone, Patrice, Goëb, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602842/
https://www.ncbi.nlm.nih.gov/pubmed/33081099
http://dx.doi.org/10.3390/jcm9103319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602842/
https://www.ncbi.nlm.nih.gov/pubmed/33081099
http://dx.doi.org/10.3390/jcm9103319

Ejemplares similares